Ankur Drugs & Pharma Ltd.
| BSE: 531683 | Sector: Health care |
| NSE: ANKURDRUGS | ISIN Code: INE238D01012 |
| BSE 05:30 | 01 Jan | Ankur Drugs & Pharma Ltd |
| NSE 05:30 | 01 Jan | Ankur Drugs & Pharma Ltd |
Ankur Drugs & Pharma Ltd. (ANKURDRUGS) - Market Capital
Market Cap
| COMPANY | LATEST(Rs) | CHG(%) | 52 Wk High | 52 Wk Low | MKT-CAP (RS CR) |
| Sun Pharma.Inds. | 586.55 | 2.00 | 627.95 | 315.20 | 140730.94 |
| Divi's Lab. | 3570.80 | 0.74 | 3913.00 | 1632.70 | 94786.89 |
| Dr Reddy's Labs | 5082.10 | 0.96 | 5514.65 | 2497.60 | 84515.32 |
| Cipla | 837.10 | 3.60 | 869.65 | 356.75 | 67507.93 |
| Aurobindo Pharma | 998.00 | 8.05 | 1023.10 | 281.15 | 58472.82 |
| Lupin | 1081.85 | 0.21 | 1121.85 | 505.00 | 49061.90 |
| Cadila Health. | 466.85 | 1.42 | 509.35 | 212.70 | 47791.44 |
| Biocon | 382.70 | -2.82 | 487.70 | 235.80 | 45924.00 |
| Torrent Pharma. | 2635.90 | -2.06 | 3040.00 | 1619.00 | 44604.70 |
| Apollo Hospitals | 2687.15 | 3.36 | 2708.40 | 1047.45 | 37383.63 |
| Alkem Lab | 3110.05 | 2.51 | 3150.00 | 1950.00 | 37180.65 |
| Gland Pharma | 2249.35 | -1.47 | 2509.05 | 1701.00 | 36776.87 |
| Piramal Enterp. | 1466.80 | -1.36 | 1727.60 | 608.00 | 33083.67 |
| Abbott India | 14535.90 | 0.84 | 18569.00 | 12218.10 | 30888.79 |
| Glaxosmi. Pharma | 1488.90 | -1.91 | 1805.00 | 1046.40 | 25223.46 |
| Ipca Labs. | 1980.90 | -3.18 | 2455.55 | 1162.00 | 25127.72 |
| Syngene Intl. | 585.50 | 0.15 | 644.65 | 201.65 | 23420.00 |
| Pfizer | 4722.00 | -1.89 | 5875.00 | 3588.15 | 21603.15 |
| Laurus Labs | 379.35 | 2.35 | 385.80 | 61.90 | 20355.92 |
| Sanofi India | 8303.45 | -1.30 | 8999.00 | 5900.05 | 19122.85 |
Quick Links for Ankur Drugs & Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
